InvestorsHub Logo

H2R

Followers 42
Posts 2177
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Tuesday, 08/02/2022 9:09:03 PM

Tuesday, August 02, 2022 9:09:03 PM

Post# of 1569
NJ Common Pension Fund D Acquires 6,275 Shares of Cytokinetics

State of New Jersey Common Pension Fund D grew its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 9.1% during the first quarter, HoldingsChannel.com reports. The fund owned 75,013 shares of the biopharmaceutical company’s stock after acquiring an additional 6,275 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Cytokinetics were worth $2,761,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CYTK. Assenagon Asset Management S.A. boosted its holdings in Cytokinetics by 3,287.6% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,489,952 shares of the biopharmaceutical company’s stock valued at $54,845,000 after acquiring an additional 1,445,969 shares during the period. Invesco Ltd. lifted its holdings in shares of Cytokinetics by 77.9% in the 4th quarter. Invesco Ltd. now owns 759,669 shares of the biopharmaceutical company’s stock worth $34,625,000 after buying an additional 332,610 shares during the period. Lisanti Capital Growth LLC bought a new position in shares of Cytokinetics in the 4th quarter worth $9,976,000. Allspring Global Investments Holdings LLC acquired a new position in Cytokinetics during the 4th quarter valued at about $9,951,000. Finally, Pictet Asset Management SA increased its position in Cytokinetics by 9.0% during the 4th quarter. Pictet Asset Management SA now owns 2,604,797 shares of the biopharmaceutical company’s stock valued at $118,727,000 after buying an additional 214,005 shares in the last quarter.



Best of luck with your investments!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News